Product Name | MF | CAS | Details |
---|
Glyurallin A | C21H20O5 | 199331-36-7 | Details |
2-(4-Aminopiperidin-1-yl)benzoic acid dihydrochloride | C12H17ClN2O2 | 2305253-03-4 | Details |
2-Chloro-1,3,2-dioxaphospholane-2-oxide | C2H4ClO3P | 6609-64-9 | Details |
Methyl 5-deoxy-2,3-O-isopropylidene-a-D-ribofuranoside | C9H16O4 | 23202-81-5 | Details |
1-Amino-3-methoxy-2-(methoxymethyl)propan-2-ol hydrochloride | 2375274-31-8 | Details |
Sulindac | C20H17FO3S | 38194-50-2 | Details |
(4-Iodophenyl)methanesulfonyl chloride | C7H6ClIO2S | 345915-64-2 | Details |
3-Amino-2-methoxypropan-1-ol hydrochloride | C4H12ClNO2 | 1423028-88-9 | Details |
Sulindac sulfone acyl-b-D-glucuronide | C26H25FO10S | 60018-37-3 | Details |
O8 OGG1 Inhibitor - Bio-X ? | C9H6Cl2N2OS | 350997-39-6 | Details |
2-(Dimethylamino)cyclopentan-1-one hydrochloride | C7H14ClNO | 1803591-04-9 | Details |
PDE5A Antibody | Details |
Myristic acid | C14H28O2 | 544-63-8 | Details |
MIS12 antibody | Details |
6,8-Dichloro-4-hydroxyquinoline-3-carbonitrile | C10H4Cl2N2O | 61338-34-9 | Details |
6-?[(Aminocarbonyl)?(2,?6-?difluorophenyl)?amino]?-?2-?(2,?4-?difluorophenyl)?-3-?pyridinecarboxamide | C19H12F4N4O2 | 479543-46-9 | Details |
1-Cyclopropyl-1H-1,2,3-triazole-4-carboxylic acid | C6H7N3O2 | 1188375-37-2 | Details |
Cy5 SE(tri SO3) | C39H47N3O13S3 | 881178-43-4 | Details |
Peptide 46 | C100H174N40O31 | 192122-40-0 | Details |
4-Phenylpentanoic acid | C11H14O2 | 16433-43-5 | Details |
3-Iodo-5-nitropyridin-4-amine | C5H4IN3O2 | 1352905-69-1 | Details |
3-Cyclopropyl-3-hydroxybutanoic acid | C7H12O3 | 65531-33-1 | Details |
2-(4,5,6,7-Tetrahydro-1-benzothiophen-2-ylformamido)acetic acid | C11H13NO3S | 1019127-35-5 | Details |
LGI3 antibody | Details |
Way 629 hydrochloride | C15H19ClN2 | 57756-44-2 | Details |
UBP53 antibody | Details |
Thymolphthalein monophosphate magnesium | C28H29MgO7P | 35106-21-9 | Details |
2,3-Dimethylbenzamide | C9H11NO | 5580-34-7 | Details |
1-tert-Butyl-3-ethynylbenzene | C12H14 | 135883-34-0 | Details |
1-(2-Phenyl-1,3-thiazol-4-yl)ethan-1-one hydrobromide | C11H10BrNOS | 1955523-30-4 | Details |
N-[(3-bromophenyl)methyl]-1-phenylcyclopentane-1-carboxamide | C19H20BrNO | 1024135-49-6 | Details |
Glycodeoxycholic Acid monohydrate | C26H45NO6 | 1079043-81-4 | Details |
N4-Hydroxycytosine | C4H5N3O2 | 20555-88-8 | Details |
ATP6AP1 Blocking Peptide | Details |
1-(5-Bromo-4-fluoro-2-hydroxyphenyl)ethanone | C8H6BrFO2 | 905454-90-2 | Details |
3-[2-(Methoxymethyl)phenyl]-2-methylprop-2-en-1-ol | C12H16O2 | 1563503-72-9 | Details |
5-Cyclopropyl-1,2,3,4-tetrahydropyrimidine-2,4-dione | C7H8N2O2 | 59698-20-3 | Details |
4,5-dihydroxyphthalonitrile | C8H4N2O2 | 300853-66-1 | Details |
4-Chloro-2,6-bis(propan-2-yl)pyrimidine | C10H15ClN2 | 1155152-94-5 | Details |
5-Bromo-2-iodo-4-methylpyrimidine | C5H4BrIN2 | 1260859-19-5 | Details |
7-Oxo-6H,7H-thieno[2,3-c]pyridine-2-carboxylic acid | C8H5NO3S | 1360929-98-1 | Details |
2-(Diethylamino)-2-(4-ethylphenyl)acetonitrile | C14H20N2 | 1017388-30-5 | Details |
KIAA1627 antibody | Details |
4-Nitro-1-N-[3-(trifluoromethyl)phenyl]benzene-1,2-diamine | C13H10F3N3O2 | 735305-34-7 | Details |
N-[4-[2-[(4-Phenoxyphenyl)amino]-4-thiazolyl]phenyl]acetamide | C23H19N3O2S | 1024466-46-3 | Details |
3-(2,2-Dimethylpropyl)-2,2-dimethylpyrrolidine | C11H23N | 1342006-48-7 | Details |
Recombinant Mouse VEGF 120 | Details |
2-[(6S)-5-{[(9H-Fluoren-9-yl)methoxy]carbonyl}-5-azaspiro[2.4]heptan-6-yl]acetic acid | C23H23NO4 | 2219354-06-8 | Details |
SF3A3 Blocking Peptide | Details |
Ethyl 3-fluoroazetidine-3-carboxylate hydrochloride | C6H11ClFNO2 | 1803596-65-7 | Details |
tert-Butyl (1-cyanocyclopropyl)carbamate | C9H14N2O2 | 507264-68-8 | Details |
Cyclopentyl(phenyl)methanamine | C12H17N | 23459-36-1 | Details |
[5-TAMRA]-Galanin (1-30) Human | Details |
2-(4-Methylpiperazin-1-yl)pyridine-4-carbonitrile | C11H14N4 | 1016501-27-1 | Details |
4-Methyl-2-(piperidin-4-yl)pyrimidine hydrochloride | C10H16ClN3 | 2137567-72-5 | Details |
4,4,5,5-Tetramethyl-2-(3,5-dihydro-2H-thiopyran-4-yl)-1,3,2-dioxaborolane | C11H21BO2S | 1264198-70-0 | Details |
DNAJA4 antibody | Details |
H-LPLMRKAYL-OH | Details |
DCK Blocking Peptide | Details |
([13C6]Leu6)-Endothelin-1 (human, bovine, dog, mouse, porcine, rat) acetate salt | Details |
3-Amino-1-[2-(methylsulfanyl)ethyl]thiourea | C4H11N3S2 | 77780-34-8 | Details |
2-Chloro-4,6-dimethyl-5-(2-methylpropyl)pyrimidine | C10H15ClN2 | 1384428-62-9 | Details |
5-Amino-N,2-dimethylbenzenesulfonamide | C8H12N2O2S | 6274-17-5 | Details |
1,4-Dibenzylpiperidine | C19H23N | 193355-49-6 | Details |
4-Fluoro-2-(trifluoromethyl)-1H-1,3-benzodiazole | C8H4F4N2 | 18645-92-6 | Details |
Ribonuclease A antibody | Details |
[(3-Bromothiophen-2-yl)methyl][2-(morpholin-4-yl)ethyl]amine | C11H17BrN2OS | 1247757-72-7 | Details |
Ethyl (4-formylphenoxy)acetate | C11H12O4 | 51264-69-8 | Details |
N'-Hydroxy-4-(piperidin-1-yl)butanimidamide | C9H19N3O | 364602-51-7 | Details |
1-(4-Bromophenyl)-1-methoxypropan-2-amine hydrochloride | C10H15BrClNO | 1432677-93-4 | Details |
tert-Butyl 4-[(1,1-dioxo-1λ?-thiolan-3-yl)amino]piperidine-1-carboxylate | C14H26N2O4S | 1154102-47-2 | Details |
2-Methyl-2-(1,2-thiazol-5-yl)propanoic acid | C7H9NO2S | 1784014-37-4 | Details |
PSA antibody | Details |
N-(Piperidin-4-yl)cyclopropanesulfonamide hydrochloride | C8H17ClN2O2S | 1403952-83-9 | Details |
PRR16 Blocking Peptide | Details |
Methyl 3-amino-1-cyclopentyl-1H-pyrazole-4-carboxylate | C10H15N3O2 | 1795474-03-1 | Details |
2-Butyl-2,3-dihydro-1H-indazol-3-one | C11H14N2O | 89438-55-1 | Details |
2-(2-Chloropyrimidin-4-yl)-2,3-dihydro-1H-isoindole | C12H10ClN3 | 488817-09-0 | Details |
4-(2-Methoxyethoxy)pyrimidin-2-amine | C7H11N3O2 | 852921-87-0 | Details |
11(Z),14(Z)-Eicosadienoic acid ethanolamide | C22H41NO2 | 162758-92-1 | Details |
1-(3-Aminopropyl)-3-methyl-1,2-dihydroquinoxalin-2-one dihydrochloride | C12H16ClN3O | 1427378-55-9 | Details |
tert-Butyl 3-[(aminocarbamothioyl)amino]pyrrolidine-1-carboxylate | 2305252-31-5 | Details |
2-[3-(4,5-Dichloro-6-oxo-1,6-dihydropyridazin-1-yl)adamantan-1-yl]acetic acid | C16H18Cl2N2O3 | 832740-18-8 | Details |
5'-Azido-5'-deoxyguanosine | C10H12N8O4 | 42204-44-4 | Details |
Methyl 5-amino-6-chloropyridine-3-carboxylate | C7H7ClN2O2 | 211915-96-7 | Details |
Asp-Asn-Glu-Asn-Val-Val-Asn-Glu-Tyr-Ser-Ser-Glu-Le | Details |
LSM2 protein (His tag) | Details |
[(4-Chlorophenyl)methyl][2-(pyrrolidin-1-yl)ethyl]amine | C13H19ClN2 | 105479-08-1 | Details |
4-Bromo-2-(morpholine-4-sulfonyl)aniline | C10H13BrN2O3S | 1179191-32-2 | Details |
(1S,3R)-3-[(2R)-2-Phenylpropanamido]cyclopentane-1-carboxylic acid | C15H19NO3 | 2027106-02-9 | Details |
4,5-dichloro-1H-pyrrole-2-carboxylic acid | C5H3Cl2NO2 | 39209-94-4 | Details |
PL-7 Antibody Positive Human Plasma | Details |
2-(4-Bromo-1,3-dimethyl-1H-pyrazol-5-yl)acetonitrile | C7H8BrN3 | 1484652-42-7 | Details |
SLC25A14 Blocking Peptide | Details |
Ethyl 3-methyl-1,2,4-oxadiazole-5-carboxylate | C6H8N2O3 | 40019-21-4 | Details |
2-(4-Methyloxan-4-yl)acetaldehyde | C8H14O2 | 2002472-33-3 | Details |
2-Nitrophenylhydrazine Hydrochloride | C6H8ClN3O2 | 6293-87-4 | Details |
2-Bromo-3-(bromomethyl)-1-fluoro-4-nitrobenzene | C7H4Br2FNO2 | 1804843-96-6 | Details |
Product Total: Product Page: | ||||
616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 |